NEW YORK, Jan. 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
IntroductionThis report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other leading players are also examined.
Features and benefits* Analyze the competitive positioning and outlook of the leading Chinese CMOs.* Assess the projected growth of the CMO market in China.* Understand the drivers and resistors of contract manufacturing market in China.* Discover contract manufacturing deals that are shaping the development of the market.* Evaluate the potential growth of contract bio-manufacturing in China.
China has emerged as one of the leading cost-competitive and quality manufacturing hubs for many multinationals including big pharma companies. Rising cost pressures compounded with economic crisis have continued to drive pharmaceutical companies to seek the cost advantages offered by Chinese CMOs.Developing finished dose exports to developed markets and gaining strength in higher margin services such as high-potency APIs and biologics will be key strategies for Chinese CMOs to overcome intense competition.The drivers of Chinese CMO market include the country's extensive scientific talent pool, and low cost of labor and raw materials. Concerns over intellectual property and product quality as well as competition from other emerging nations are the key market resistors.
Your key questions answered
* How is the